GlassScriptPhysician profile
Lauren B Tyler
NPI 1659007508
$1,020.30
in general payments reported to CMS, 2019-2025
16 companies · $133 in 2025
The $133 reported for 2025 was less than what a typical Family provider received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $145 · 2023: $327 · 2024: $415 · 2025: $133.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $875.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $874.93 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $280.76 | 2023-2024 | Farxiga, Airsupra |
| Calliditas Therapeutics US INC. | $145.68 | 2023-2024 | Tarpeyo |
| Horizon Therapeutics Plc | $124.40 | 2022 | |
| Medtronic, INC. | $111.06 | 2023 | Ellipsys Vascular Access System |
| Abbvie INC. | $55.81 | 2024-2025 | |
| Merz North America, INC. | $46.94 | 2025 | |
| Lilly USA, LLC | $41.82 | 2024 | Mounjaro, Zepbound |
| Opko Pharmaceuticals, LLC | $38.95 | 2023 | Rayaldee |
| Ardelyx, INC. | $30.28 | 2023 | Ibsrela |
| Pfizer INC. | $25.69 | 2024 | |
| Sobi, INC | $23.57 | 2025 | |
| Galderma Laboratories, L.P. | $23.46 | 2025 | |
| Owp Pharmaceuticals, INC. | $22.05 | 2024 | Subvenite |
| Fresenius USA Marketing, INC. | $20.97 | 2022 | |
| Idorsia Pharmaceuticals US INC | $15.28 | 2025 | Quviviq |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Exact Sciences Corporation | $13.58 | 2024 | Cologuard Collection Kit |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Lauren Tyler listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.